Total Payments
$11,837
2024 Payments
$1,874
Companies
52
Transactions
675
Medicare Patients
4,611
Medicare Billing
$289,253
Payment Breakdown by Category
Food & Beverage$11,748 (99.2%)
Education$89.84 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,748 | 670 | 99.2% |
| Education | $89.84 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,299 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $905.12 | 42 | $0 (2024) |
| Novo Nordisk Inc | $784.96 | 50 | $0 (2024) |
| Amgen Inc. | $742.84 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $715.31 | 38 | $0 (2024) |
| AbbVie Inc. | $704.99 | 35 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $637.01 | 62 | $0 (2024) |
| Lilly USA, LLC | $595.47 | 43 | $0 (2024) |
| ITI, Inc. | $448.56 | 21 | $0 (2023) |
| Allergan, Inc. | $370.49 | 32 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,874 | 106 | GlaxoSmithKline, LLC. ($229.91) |
| 2023 | $2,253 | 113 | GlaxoSmithKline, LLC. ($387.73) |
| 2022 | $1,539 | 83 | ITI, Inc. ($232.71) |
| 2021 | $1,368 | 60 | MERZ NORTH AMERICA, INC. ($199.12) |
| 2020 | $1,214 | 72 | AstraZeneca Pharmaceuticals LP ($227.09) |
| 2019 | $1,058 | 77 | Amgen Inc. ($187.09) |
| 2018 | $1,219 | 76 | Janssen Pharmaceuticals, Inc ($226.64) |
| 2017 | $1,312 | 88 | AstraZeneca Pharmaceuticals LP ($215.03) |
All Payment Transactions
675 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Obesity | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Biological | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,073 | 1,349 | $176,492 | $74,017 |
| 2022 | 24 | 1,243 | 1,608 | $162,760 | $75,543 |
| 2021 | 21 | 1,331 | 1,697 | $159,060 | $73,687 |
| 2020 | 21 | 964 | 1,377 | $176,698 | $66,006 |
Total Patients
4,611
Total Services
6,031
Medicare Billing
$289,253
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 334 | $66,548 | $24,583 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $18,187 | $13,243 | 72.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $12,638 | $10,096 | 79.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 102 | $14,803 | $4,757 | 32.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 53 | 53 | $11,395 | $3,763 | 33.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 53 | 53 | $3,975 | $3,672 | 92.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,028 | $2,012 | 99.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 119 | 119 | $5,117 | $2,012 | 39.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 104 | 104 | $4,368 | $1,756 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $1,404 | $1,350 | 96.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 15 | 15 | $9,750 | $1,236 | 12.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 17 | 18 | $9,900 | $1,000 | 10.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 22 | $3,864 | $973.96 | 25.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 36 | $936.00 | $917.28 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 97 | $2,425 | $806.40 | 33.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 82 | $4,756 | $735.64 | 15.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 13 | 15 | $1,530 | $595.19 | 38.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 20 | $1,220 | $262.40 | 21.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 15 | 24 | $360.00 | $109.36 | 30.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 14 | 14 | $616.00 | $79.24 | 12.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 28 | $672.00 | $57.20 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 328 | $49,200 | $22,494 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $15,940 | $13,540 | 84.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 124 | 124 | $26,660 | $9,695 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 111 | $11,100 | $5,683 | 51.2% |
About Dr. Michael Busman, MD
Dr. Michael Busman, MD is a Family Medicine healthcare provider based in Americus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073584504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Busman, MD has received a total of $11,837 in payments from pharmaceutical and medical device companies, with $1,874 received in 2024. These payments were reported across 675 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($11,748).
As a Medicare-enrolled provider, Busman has provided services to 4,611 Medicare beneficiaries, totaling 6,031 services with total Medicare billing of $289,253. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Americus, GA
- Active Since 02/01/2006
- Last Updated 12/23/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073584504
Products in Payments
- XARELTO (Drug) $549.79
- TRELEGY ELLIPTA (Drug) $545.77
- FARXIGA (Drug) $534.63
- CAPLYTA (Drug) $507.26
- VRAYLAR (Drug) $444.73
- Ozempic (Drug) $393.98
- JARDIANCE (Drug) $347.46
- Kerendia (Drug) $319.41
- Dexcom G6 Transmitter (Medical Supply) $282.66
- UBRELVY (Drug) $246.17
- INGREZZA (Drug) $237.10
- BREZTRI (Drug) $220.68
- REXULTI (Drug) $214.64
- ELIQUIS (Drug) $213.30
- Otezla (Drug) $212.13
- TRULICITY (Drug) $210.49
- Prolia (Biological) $209.01
- SYMBICORT (Drug) $180.63
- MOUNJARO (Drug) $171.95
- XIFAXAN (Drug) $166.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Americus
Jill Olek, M.d, M.D
Family Medicine — Payments: $8,713
Family Medicine $8,713
Dr. Malcolm Floyd, M.d, M.D
Family Medicine — Payments: $4,168
Family Medicine $4,168
Dr. Bennie Law, Md, MD
Family Medicine — Payments: $3,763
Family Medicine $3,763
Michael Raines, M.d, M.D
Family Medicine — Payments: $2,883
Family Medicine $2,883
Ms. Bernadette Blount, M.d, M.D
Family Medicine — Payments: $834.34
Family Medicine $834.34
Dr. Jeffrey Nasworthy, Md, MD
Family Medicine — Payments: $26.39
Family Medicine $26.39